Loading…
Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations
Abstract Background In recent years different IRT/PAP protocols have been evaluated, but the individual performance remains unclear. To optimize the IRT/PAP strategy we compared protocols from three regional CF newborn screening centers (Heidelberg, Dresden, and Prague). Methods We evaluated the eff...
Saved in:
Published in: | Journal of cystic fibrosis 2014-01, Vol.13 (1), p.15-23 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3 |
container_end_page | 23 |
container_issue | 1 |
container_start_page | 15 |
container_title | Journal of cystic fibrosis |
container_volume | 13 |
creator | Sommerburg, Olaf Krulisova, Veronika Hammermann, Jutta Lindner, Martin Stahl, Mirjam Muckenthaler, Martina Kohlmueller, Dirk Happich, Margit Kulozik, Andreas E Votava, Felix Balascakova, Miroslava Skalicka, Veronika Stopsack, Marina Gahr, Manfred Macek, Milan Mall, Marcus A Hoffmann, Georg F |
description | Abstract Background In recent years different IRT/PAP protocols have been evaluated, but the individual performance remains unclear. To optimize the IRT/PAP strategy we compared protocols from three regional CF newborn screening centers (Heidelberg, Dresden, and Prague). Methods We evaluated the effect of elevating the IRT-cut-off from 50 to 65 μg/l (~ 97.5th to ~ 99.0th percentile), the need of a failsafe protocol (FS, IRT ≥ 99.9th percentile) and the relative performance using either two IRT-dependent PAP-cut-offs or one PAP-cut-off. Findings Elevation of the IRT cut-off to 65 μg/l (~ 99.0th percentile) increased the PPV significantly (Dresden: 0.065 vs. 0.080, p < 0.0001, Prague: 0.052 vs. 0.074, p < 0.0001) without reducing sensitivity. All three IRT/PAP protocols showed a trend towards a higher sensitivity with FS than without and when using one PAP-cut-off instead of two IRT-dependent PAP-cut-offs. Conclusions For best performance we suggest an IRT/PAP protocol with an IRT-cut-off close to the 99.0th percentile, FS, and a single PAP-cut-off. |
doi_str_mv | 10.1016/j.jcf.2013.06.003 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490735359</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1569199313001082</els_id><sourcerecordid>1490735359</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3</originalsourceid><addsrcrecordid>eNp9kUFv1DAUhCMEoqXwA7ggH7kkvBdvEltISNWqQKVKVFDOltd-Fg5ZO9hJq_33eLWFAwcufj58M9LMVNVrhAYB-3djMxrXtIC8gb4B4E-qcxQDrztAeFr-XS9rlJKfVS9yHgFwgEE8r85aLiS2gziv7rdxP-vkcwwsOma9c5QoLOz66119e3nL5hSXaOKU2RJZNokosEAPu5hCZi4mZg558YY5v0sx-8x8YMuPgjFTbJKe2NWa4kw6sDnO66QXH0N-WT1zesr06vFeVN8_Xt1tP9c3Xz5dby9varPpcKmt1a1tN7aX6HpsSXbWWjcIDRvZCwAt3aBFebGzgkBw0zvBu8INHO1g-UX19uRbYvxaKS9q77OhadKB4poVbiQMvOOdLCieUFNy5EROzcnvdTooBHWsW42q1K2OdSvoVam7aN482q-7Pdm_ij_9FuD9CaAS8t5TUtl4CoasT2QWZaP_r_2Hf9Rm8sEbPf2kA-UxrimU9hSq3CpQ3457H-dGXqYG0fLf3P2mkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490735359</pqid></control><display><type>article</type><title>Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations</title><source>Elsevier</source><creator>Sommerburg, Olaf ; Krulisova, Veronika ; Hammermann, Jutta ; Lindner, Martin ; Stahl, Mirjam ; Muckenthaler, Martina ; Kohlmueller, Dirk ; Happich, Margit ; Kulozik, Andreas E ; Votava, Felix ; Balascakova, Miroslava ; Skalicka, Veronika ; Stopsack, Marina ; Gahr, Manfred ; Macek, Milan ; Mall, Marcus A ; Hoffmann, Georg F</creator><creatorcontrib>Sommerburg, Olaf ; Krulisova, Veronika ; Hammermann, Jutta ; Lindner, Martin ; Stahl, Mirjam ; Muckenthaler, Martina ; Kohlmueller, Dirk ; Happich, Margit ; Kulozik, Andreas E ; Votava, Felix ; Balascakova, Miroslava ; Skalicka, Veronika ; Stopsack, Marina ; Gahr, Manfred ; Macek, Milan ; Mall, Marcus A ; Hoffmann, Georg F</creatorcontrib><description>Abstract Background In recent years different IRT/PAP protocols have been evaluated, but the individual performance remains unclear. To optimize the IRT/PAP strategy we compared protocols from three regional CF newborn screening centers (Heidelberg, Dresden, and Prague). Methods We evaluated the effect of elevating the IRT-cut-off from 50 to 65 μg/l (~ 97.5th to ~ 99.0th percentile), the need of a failsafe protocol (FS, IRT ≥ 99.9th percentile) and the relative performance using either two IRT-dependent PAP-cut-offs or one PAP-cut-off. Findings Elevation of the IRT cut-off to 65 μg/l (~ 99.0th percentile) increased the PPV significantly (Dresden: 0.065 vs. 0.080, p < 0.0001, Prague: 0.052 vs. 0.074, p < 0.0001) without reducing sensitivity. All three IRT/PAP protocols showed a trend towards a higher sensitivity with FS than without and when using one PAP-cut-off instead of two IRT-dependent PAP-cut-offs. Conclusions For best performance we suggest an IRT/PAP protocol with an IRT-cut-off close to the 99.0th percentile, FS, and a single PAP-cut-off.</description><identifier>ISSN: 1569-1993</identifier><identifier>EISSN: 1873-5010</identifier><identifier>DOI: 10.1016/j.jcf.2013.06.003</identifier><identifier>PMID: 23891278</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antigens, Neoplasm - analysis ; Antigens, Neoplasm - blood ; Antigens, Neoplasm - genetics ; Biochemical screening ; Biomarkers, Tumor - analysis ; Biomarkers, Tumor - blood ; Biomarkers, Tumor - genetics ; Chemistry, Clinical - methods ; Chemistry, Clinical - standards ; Cystic fibrosis ; Cystic Fibrosis - blood ; Cystic Fibrosis - diagnosis ; Cystic Fibrosis - genetics ; Cystic Fibrosis Transmembrane Conductance Regulator - genetics ; Dried Blood Spot Testing - methods ; Dried Blood Spot Testing - standards ; Europe ; Genetic Testing - methods ; Genetic Testing - standards ; Humans ; Immunoreactive trypsinogen ; Infant, Newborn ; Lectins, C-Type - analysis ; Lectins, C-Type - blood ; Lectins, C-Type - genetics ; Neonatal Screening - methods ; Neonatal Screening - standards ; Newborn screening ; Pancreatitis associated protein ; Pancreatitis-Associated Proteins ; Prospective Studies ; Pulmonary/Respiratory ; Retrospective Studies ; Sensitivity and Specificity ; Trypsinogen - analysis ; Trypsinogen - blood ; Trypsinogen - genetics</subject><ispartof>Journal of cystic fibrosis, 2014-01, Vol.13 (1), p.15-23</ispartof><rights>European Cystic Fibrosis Society.</rights><rights>2013 European Cystic Fibrosis Society.</rights><rights>2013.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3</citedby><cites>FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23891278$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sommerburg, Olaf</creatorcontrib><creatorcontrib>Krulisova, Veronika</creatorcontrib><creatorcontrib>Hammermann, Jutta</creatorcontrib><creatorcontrib>Lindner, Martin</creatorcontrib><creatorcontrib>Stahl, Mirjam</creatorcontrib><creatorcontrib>Muckenthaler, Martina</creatorcontrib><creatorcontrib>Kohlmueller, Dirk</creatorcontrib><creatorcontrib>Happich, Margit</creatorcontrib><creatorcontrib>Kulozik, Andreas E</creatorcontrib><creatorcontrib>Votava, Felix</creatorcontrib><creatorcontrib>Balascakova, Miroslava</creatorcontrib><creatorcontrib>Skalicka, Veronika</creatorcontrib><creatorcontrib>Stopsack, Marina</creatorcontrib><creatorcontrib>Gahr, Manfred</creatorcontrib><creatorcontrib>Macek, Milan</creatorcontrib><creatorcontrib>Mall, Marcus A</creatorcontrib><creatorcontrib>Hoffmann, Georg F</creatorcontrib><title>Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations</title><title>Journal of cystic fibrosis</title><addtitle>J Cyst Fibros</addtitle><description>Abstract Background In recent years different IRT/PAP protocols have been evaluated, but the individual performance remains unclear. To optimize the IRT/PAP strategy we compared protocols from three regional CF newborn screening centers (Heidelberg, Dresden, and Prague). Methods We evaluated the effect of elevating the IRT-cut-off from 50 to 65 μg/l (~ 97.5th to ~ 99.0th percentile), the need of a failsafe protocol (FS, IRT ≥ 99.9th percentile) and the relative performance using either two IRT-dependent PAP-cut-offs or one PAP-cut-off. Findings Elevation of the IRT cut-off to 65 μg/l (~ 99.0th percentile) increased the PPV significantly (Dresden: 0.065 vs. 0.080, p < 0.0001, Prague: 0.052 vs. 0.074, p < 0.0001) without reducing sensitivity. All three IRT/PAP protocols showed a trend towards a higher sensitivity with FS than without and when using one PAP-cut-off instead of two IRT-dependent PAP-cut-offs. Conclusions For best performance we suggest an IRT/PAP protocol with an IRT-cut-off close to the 99.0th percentile, FS, and a single PAP-cut-off.</description><subject>Antigens, Neoplasm - analysis</subject><subject>Antigens, Neoplasm - blood</subject><subject>Antigens, Neoplasm - genetics</subject><subject>Biochemical screening</subject><subject>Biomarkers, Tumor - analysis</subject><subject>Biomarkers, Tumor - blood</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Chemistry, Clinical - methods</subject><subject>Chemistry, Clinical - standards</subject><subject>Cystic fibrosis</subject><subject>Cystic Fibrosis - blood</subject><subject>Cystic Fibrosis - diagnosis</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</subject><subject>Dried Blood Spot Testing - methods</subject><subject>Dried Blood Spot Testing - standards</subject><subject>Europe</subject><subject>Genetic Testing - methods</subject><subject>Genetic Testing - standards</subject><subject>Humans</subject><subject>Immunoreactive trypsinogen</subject><subject>Infant, Newborn</subject><subject>Lectins, C-Type - analysis</subject><subject>Lectins, C-Type - blood</subject><subject>Lectins, C-Type - genetics</subject><subject>Neonatal Screening - methods</subject><subject>Neonatal Screening - standards</subject><subject>Newborn screening</subject><subject>Pancreatitis associated protein</subject><subject>Pancreatitis-Associated Proteins</subject><subject>Prospective Studies</subject><subject>Pulmonary/Respiratory</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><subject>Trypsinogen - analysis</subject><subject>Trypsinogen - blood</subject><subject>Trypsinogen - genetics</subject><issn>1569-1993</issn><issn>1873-5010</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAUhCMEoqXwA7ggH7kkvBdvEltISNWqQKVKVFDOltd-Fg5ZO9hJq_33eLWFAwcufj58M9LMVNVrhAYB-3djMxrXtIC8gb4B4E-qcxQDrztAeFr-XS9rlJKfVS9yHgFwgEE8r85aLiS2gziv7rdxP-vkcwwsOma9c5QoLOz66119e3nL5hSXaOKU2RJZNokosEAPu5hCZi4mZg558YY5v0sx-8x8YMuPgjFTbJKe2NWa4kw6sDnO66QXH0N-WT1zesr06vFeVN8_Xt1tP9c3Xz5dby9varPpcKmt1a1tN7aX6HpsSXbWWjcIDRvZCwAt3aBFebGzgkBw0zvBu8INHO1g-UX19uRbYvxaKS9q77OhadKB4poVbiQMvOOdLCieUFNy5EROzcnvdTooBHWsW42q1K2OdSvoVam7aN482q-7Pdm_ij_9FuD9CaAS8t5TUtl4CoasT2QWZaP_r_2Hf9Rm8sEbPf2kA-UxrimU9hSq3CpQ3457H-dGXqYG0fLf3P2mkA</recordid><startdate>20140101</startdate><enddate>20140101</enddate><creator>Sommerburg, Olaf</creator><creator>Krulisova, Veronika</creator><creator>Hammermann, Jutta</creator><creator>Lindner, Martin</creator><creator>Stahl, Mirjam</creator><creator>Muckenthaler, Martina</creator><creator>Kohlmueller, Dirk</creator><creator>Happich, Margit</creator><creator>Kulozik, Andreas E</creator><creator>Votava, Felix</creator><creator>Balascakova, Miroslava</creator><creator>Skalicka, Veronika</creator><creator>Stopsack, Marina</creator><creator>Gahr, Manfred</creator><creator>Macek, Milan</creator><creator>Mall, Marcus A</creator><creator>Hoffmann, Georg F</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140101</creationdate><title>Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations</title><author>Sommerburg, Olaf ; Krulisova, Veronika ; Hammermann, Jutta ; Lindner, Martin ; Stahl, Mirjam ; Muckenthaler, Martina ; Kohlmueller, Dirk ; Happich, Margit ; Kulozik, Andreas E ; Votava, Felix ; Balascakova, Miroslava ; Skalicka, Veronika ; Stopsack, Marina ; Gahr, Manfred ; Macek, Milan ; Mall, Marcus A ; Hoffmann, Georg F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Antigens, Neoplasm - analysis</topic><topic>Antigens, Neoplasm - blood</topic><topic>Antigens, Neoplasm - genetics</topic><topic>Biochemical screening</topic><topic>Biomarkers, Tumor - analysis</topic><topic>Biomarkers, Tumor - blood</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Chemistry, Clinical - methods</topic><topic>Chemistry, Clinical - standards</topic><topic>Cystic fibrosis</topic><topic>Cystic Fibrosis - blood</topic><topic>Cystic Fibrosis - diagnosis</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator - genetics</topic><topic>Dried Blood Spot Testing - methods</topic><topic>Dried Blood Spot Testing - standards</topic><topic>Europe</topic><topic>Genetic Testing - methods</topic><topic>Genetic Testing - standards</topic><topic>Humans</topic><topic>Immunoreactive trypsinogen</topic><topic>Infant, Newborn</topic><topic>Lectins, C-Type - analysis</topic><topic>Lectins, C-Type - blood</topic><topic>Lectins, C-Type - genetics</topic><topic>Neonatal Screening - methods</topic><topic>Neonatal Screening - standards</topic><topic>Newborn screening</topic><topic>Pancreatitis associated protein</topic><topic>Pancreatitis-Associated Proteins</topic><topic>Prospective Studies</topic><topic>Pulmonary/Respiratory</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><topic>Trypsinogen - analysis</topic><topic>Trypsinogen - blood</topic><topic>Trypsinogen - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sommerburg, Olaf</creatorcontrib><creatorcontrib>Krulisova, Veronika</creatorcontrib><creatorcontrib>Hammermann, Jutta</creatorcontrib><creatorcontrib>Lindner, Martin</creatorcontrib><creatorcontrib>Stahl, Mirjam</creatorcontrib><creatorcontrib>Muckenthaler, Martina</creatorcontrib><creatorcontrib>Kohlmueller, Dirk</creatorcontrib><creatorcontrib>Happich, Margit</creatorcontrib><creatorcontrib>Kulozik, Andreas E</creatorcontrib><creatorcontrib>Votava, Felix</creatorcontrib><creatorcontrib>Balascakova, Miroslava</creatorcontrib><creatorcontrib>Skalicka, Veronika</creatorcontrib><creatorcontrib>Stopsack, Marina</creatorcontrib><creatorcontrib>Gahr, Manfred</creatorcontrib><creatorcontrib>Macek, Milan</creatorcontrib><creatorcontrib>Mall, Marcus A</creatorcontrib><creatorcontrib>Hoffmann, Georg F</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cystic fibrosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sommerburg, Olaf</au><au>Krulisova, Veronika</au><au>Hammermann, Jutta</au><au>Lindner, Martin</au><au>Stahl, Mirjam</au><au>Muckenthaler, Martina</au><au>Kohlmueller, Dirk</au><au>Happich, Margit</au><au>Kulozik, Andreas E</au><au>Votava, Felix</au><au>Balascakova, Miroslava</au><au>Skalicka, Veronika</au><au>Stopsack, Marina</au><au>Gahr, Manfred</au><au>Macek, Milan</au><au>Mall, Marcus A</au><au>Hoffmann, Georg F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations</atitle><jtitle>Journal of cystic fibrosis</jtitle><addtitle>J Cyst Fibros</addtitle><date>2014-01-01</date><risdate>2014</risdate><volume>13</volume><issue>1</issue><spage>15</spage><epage>23</epage><pages>15-23</pages><issn>1569-1993</issn><eissn>1873-5010</eissn><abstract>Abstract Background In recent years different IRT/PAP protocols have been evaluated, but the individual performance remains unclear. To optimize the IRT/PAP strategy we compared protocols from three regional CF newborn screening centers (Heidelberg, Dresden, and Prague). Methods We evaluated the effect of elevating the IRT-cut-off from 50 to 65 μg/l (~ 97.5th to ~ 99.0th percentile), the need of a failsafe protocol (FS, IRT ≥ 99.9th percentile) and the relative performance using either two IRT-dependent PAP-cut-offs or one PAP-cut-off. Findings Elevation of the IRT cut-off to 65 μg/l (~ 99.0th percentile) increased the PPV significantly (Dresden: 0.065 vs. 0.080, p < 0.0001, Prague: 0.052 vs. 0.074, p < 0.0001) without reducing sensitivity. All three IRT/PAP protocols showed a trend towards a higher sensitivity with FS than without and when using one PAP-cut-off instead of two IRT-dependent PAP-cut-offs. Conclusions For best performance we suggest an IRT/PAP protocol with an IRT-cut-off close to the 99.0th percentile, FS, and a single PAP-cut-off.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23891278</pmid><doi>10.1016/j.jcf.2013.06.003</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1569-1993 |
ispartof | Journal of cystic fibrosis, 2014-01, Vol.13 (1), p.15-23 |
issn | 1569-1993 1873-5010 |
language | eng |
recordid | cdi_proquest_miscellaneous_1490735359 |
source | Elsevier |
subjects | Antigens, Neoplasm - analysis Antigens, Neoplasm - blood Antigens, Neoplasm - genetics Biochemical screening Biomarkers, Tumor - analysis Biomarkers, Tumor - blood Biomarkers, Tumor - genetics Chemistry, Clinical - methods Chemistry, Clinical - standards Cystic fibrosis Cystic Fibrosis - blood Cystic Fibrosis - diagnosis Cystic Fibrosis - genetics Cystic Fibrosis Transmembrane Conductance Regulator - genetics Dried Blood Spot Testing - methods Dried Blood Spot Testing - standards Europe Genetic Testing - methods Genetic Testing - standards Humans Immunoreactive trypsinogen Infant, Newborn Lectins, C-Type - analysis Lectins, C-Type - blood Lectins, C-Type - genetics Neonatal Screening - methods Neonatal Screening - standards Newborn screening Pancreatitis associated protein Pancreatitis-Associated Proteins Prospective Studies Pulmonary/Respiratory Retrospective Studies Sensitivity and Specificity Trypsinogen - analysis Trypsinogen - blood Trypsinogen - genetics |
title | Comparison of different IRT-PAP protocols to screen newborns for cystic fibrosis in three central European populations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T10%3A29%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20different%20IRT-PAP%20protocols%20to%20screen%20newborns%20for%20cystic%20fibrosis%20in%20three%20central%20European%20populations&rft.jtitle=Journal%20of%20cystic%20fibrosis&rft.au=Sommerburg,%20Olaf&rft.date=2014-01-01&rft.volume=13&rft.issue=1&rft.spage=15&rft.epage=23&rft.pages=15-23&rft.issn=1569-1993&rft.eissn=1873-5010&rft_id=info:doi/10.1016/j.jcf.2013.06.003&rft_dat=%3Cproquest_cross%3E1490735359%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-dda2d24d691f612e95dddf78a0496800a9f7a8a9f15d8e083c6f835e95731d7d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490735359&rft_id=info:pmid/23891278&rfr_iscdi=true |